Skip to main content
Log in

Association between preoperative biologic use and surgical morbidity in patients with Crohn’s disease

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

We evaluated the influence of preoperative treatments with biologics on surgical morbidity in patients with Crohn’s disease (CD).

Methods

We reviewed the surveillance data of patients with CD who underwent surgery between April 2018 and April 2021. The possible risk factors for morbidity were analyzed.

Results

A total of 305 surgically treated patients were included. Anti-TNF alpha agents and ustekinumab were used in 92 and 27 patients, respectively, within 12 weeks before surgery. There were no cases of mortality. In total, 70/305 (23.0%) patients developed a complication, and 42/305 (13.8%) patients developed a surgical site infection (SSI) (17 incisional SSIs and 35 organ/space SSIs). Current smoking status (OR 3.44), emergent/urgent surgery (OR 6.85), and abdominoperineal resection (APR) (OR 14.93) were identified as risk factors for total complications. Penetrating disease (OR 14.55) was identified as a risk factor for incisional SSIs. Current smoking status (OR 7.09), an American Society of Anesthesiologists (ASA) score greater than 3 (OR 5.85), a postoperative blood sugar level over 155 mg/dL (OR 4.37), and APR (OR 207.95) were identified as risk factors for organ/space SSIs.

Conclusions

No correlation between preoperative treatment with biologics and surgical mortality or morbidity was found. However, we should perform further analyses on a larger number of patients because the analyses may be limited by selection bias for treatment and several confounding factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Van Assche G, Rutgeerts P (2000) Anti-TNF agents in Crohn’s disease. Expert Opin Investig Drugs 9:103–111

    Article  Google Scholar 

  2. Hanauer SB, Feagan BG, Lichtenstein GR et al (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet 359:1541–1549

    Article  CAS  Google Scholar 

  3. Stidham RW, Lee TC, Higgins PD et al (2014) Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn’s disease. Aliment Pharmacol Ther 39:1349–1362

    Article  CAS  Google Scholar 

  4. Xu Y, Yang L, An P et al (2019) Meta-analysis: the influence of preoperative infliximab use on postoperative complications of Crohn’s disease. Inflamm Bowel Dis 25:261–269

    Article  Google Scholar 

  5. Lin YS, Cheng SW, Wang YH et al (2019) Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumor necrosis factor agents for Crohn’s disease. Aliment Pharmacol Ther 49:966–977

    Article  Google Scholar 

  6. Adamina M, Bonovas S, Raine T et al (2020) ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment. J Crohns Colitis 14:155–168

    Article  Google Scholar 

  7. Lightner AL, McKenna NP, Tse CS et al (2018) Postoperative outcomes in ustekinumab-treated patients undergoing abdominal operations for Crohn’s disease. J Crohns Colitis 12:402–407

    Article  Google Scholar 

  8. Shim HH, Ma C, Kotze PG et al (2018) Preoperative ustekinumab treatment is not associated with increased postoperative complications in Crohn’s disease: a Canadian multi-centre observational cohort study. J Can Assoc Gastroenterol 1:115–123

    Article  Google Scholar 

  9. Garg R, Mohan BP, Ponnada S et al (2021) Postoperative outcomes after preoperative ustekinumab exposure in patients with Crohn’s disease: a systematic review and meta-analysis. Ann Gastroenterol 34:691–698

    PubMed  PubMed Central  Google Scholar 

  10. García MJ, Rivero M, Miranda-Bautista J et al (2021) Impact of biological agents on postsurgical complications in inflammatory bowel disease: a multicentre study of Geteccu. J Clin Med 10:4402

    Article  Google Scholar 

  11. Smith RL, Bohl JK, McElearney ST et al (2004) Wound infection after elective colorectal resection. Ann Surg 239:599–607

    Article  Google Scholar 

  12. Louis E, Collard A, Oger AF et al (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49:777–782

    Article  CAS  Google Scholar 

  13. Uchino M, Ikeuchi H, Bando T et al (2019) Efficacy of preoperative oral antibiotic prophylaxis for the prevention of surgical site infections in patients with Crohn’s disease: a randomized controlled trial. Ann Surg 269:420–426

    Article  Google Scholar 

  14. Dindo D, Demartines N et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

    Article  Google Scholar 

  15. Culver DH, Horan TC, Gaynes RP et al (1991) Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 91:152S-158S

    Article  CAS  Google Scholar 

  16. Horan TC, Gaynes RP, Martone WJ et al (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606–608

    Article  CAS  Google Scholar 

  17. Narula N, Charleton D, Marshall JK (2013) Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther 37:1057–1064

    Article  CAS  Google Scholar 

  18. Ganesh Kumar N, Khouri AN, Byrn JC et al (2021) The role of autologous flap reconstruction in patients with Crohn’s disease undergoing abdominoperineal resection. Dis Colon Rectum 64:429–437

    Article  Google Scholar 

  19. Pędziwiatr M, Mavrikis J, Witowski J et al (2018) Current status of enhanced recovery after surgery (ERAS) protocol in gastrointestinal surgery. Med Oncol 35:95

    Article  Google Scholar 

  20. Global guidelines for the prevention of surgical site infection. http://apps.who.int/iris/bitstream/10665/250680/1/9789241549882-eng.pdf. Accessed 1 Dec 2016

  21. Oshima T, Takesue Y, Ikeuchi H et al (2013) Preoperative oral antibiotics and intravenous antimicrobial prophylaxis reduce the incidence of surgical site infections in patients with ulcerative colitis undergoing IPAA. Dis Colon Rectum 56:1149–1155

    Article  Google Scholar 

  22. Cornillie F, Shealy D, D’Haens G et al (2001) Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease. Aliment Pharmacol Ther 5:463–473

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Motoi Uchino, conception and design of the study, data analysis, and drafting of the article; Yuki Horio, Ryuichi Kuwahara, Tomohiro Minagawa, Kusunoki Kurando, Yoshiko Goto, Naohito Beppu, and Masataka Ikeda, data acquisition; Kazuhiko Nakajima, Kaoru Ichiki, and Takashi Ueda, SSI data acquisition (infection control team); Hiroki Ikeuchi and Masataka Ikeda, interpretation of the data and critical revision of the article.

Corresponding author

Correspondence to Motoi Uchino.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uchino, M., Ikeuchi, H., Horio, Y. et al. Association between preoperative biologic use and surgical morbidity in patients with Crohn’s disease. Int J Colorectal Dis 37, 999–1010 (2022). https://doi.org/10.1007/s00384-022-04140-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-022-04140-8

Keywords

Navigation